[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$glsi

Greenwich LifeSciences' Phase III breast cancer trial, FLAMINGO-01, has screened over 1000 patients, with enrollment in the open-label arm fully completed. The company's immunotherapy candidate, GLSI-100, shows promising results in preventing breast cancer recurrence.

About $glsi

Greenwich LifeSciences is a biotechnology company focused on developing treatments for breast cancer.

Insights

$glsi sentiment is up XXX% from the previous week.
$glsi posts created is up XXX% from the previous month.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +9.80%
X Year: XXXXXXXXX +137%
1-Year High: XXXXXX on 2025-09-25
1-Year Low: X on 2025-09-24

Engagements by network (24h): Reddit: XX X: XXX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XXX +23%
X Months: XXXXX +169%
X Year: XXXXX +338%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-23

Mentions by network (24h): Reddit: X X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $glsi in the last XX hours which is no change from in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XX +35%
X Months: XXX +731%
X Year: XXX +579%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-23

The most influential creators that mention $glsi in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@RedChip	X	XXXXX	X	XXX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +50%
X Month: XXX% +50%
X Months: XXX% no change
X Year: XXX% +33%
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-11-30

Most Supportive Themes:

FDA Fast Track Designation: (33%) The FDA has granted Fast Track designation to GLSI-100, a significant step in the development of treatments for breast cancer.
Phase III Trial Progress: (33%) Greenwich LifeSciences' Phase III breast cancer trial, FLAMINGO-01, is showing progress with site activations and enrollment underway.

Most Critical Themes:

Top $glsi Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"📢 Greenwich LifeSciences $GLSI Hits Major Phase X Milestone: Open Label Arm Fully Enrolled @GreenwichLS has finished enrollment of the non-HLA-A*02 open label arm in its Phase III trial of GLSI-100 an immunotherapy aimed at preventing breast cancer recurrence. Preliminary observations show immune response and safety patterns tracking closely with Phase IIb results where recurrence was reduced by up to XX% and no metastatic recurrences were reported. Read the Full Announcement: $GLSI $PFE $LLY $JNJ $NVS $AZN $MRK $HOLX $IMCR"
X Link @RedChip 2025-12-08T14:54Z 6098 followers, XXX engagements

"$GLSI On Wednesday Greenwich LifeSciences announced screening over 1000 patients in the Flamingo-01 Phase III trial for GLSI-100 (GP2+GM-CSF) immunotherapy in high-risk HER2+ breast cancer with XX% HLA-A02 randomized and XX% non-HLA-A02 in open-label across XXX sites. Why It's Good This adaptive continuation (per Steering Committee) leverages momentum (150 screened/quarter) for multiple interim analyses higher event accrual HLA subgroup data and broader labeling potentialenhancing regulatory/commercial value without risking core power (80% at XX iBCFS events). No Timeline Delay Event-driven"
X Link @intimepk 2025-12-06T00:20Z XX followers, XXX engagements

"$CHPT Q3 FY25 revenue $105.7M (+6%) beat estimates; EPS -XXXX beat; debt cut $172M. Largest NA EV network (342K ports); software/hardware integration; OEM partnerships. Today's Rise: Earnings beat sparked XX% surge on strong guidance. $NFE $COO $GLSI $SNSE $AXGN $INHD $PRAX"
X Link @TrendTrader_777 2025-12-05T12:59Z XXX followers, XXX engagements

"🎥 Greenwich LifeSciences $GLSI: CEO Snehal Patel Discusses GP2 Immunotherapy and Phase III Strategy In our most recent interview CEO Snehal Patel outlines the companys clinical and strategic roadmap for GP2 an immunotherapy designed to prevent breast cancer recurrences in HER2-positive patients following surgery. Key Takeaways for Investors: Robust Phase IIb Data: GP2 achieved over XX% reduction in recurrence rates over five years significantly outperforming existing therapies in the adjuvant setting. Strong Safety Profile: No serious adverse events reported across XXX patients in four"
X Link @RedChip 2025-12-04T14:40Z 6092 followers, XXX engagements